Genscript Biotech Corporation
GNNSF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,694,033 | $5,142,804 | $6,207,519 | $9,239,219 |
| - Cash | $131,990 | $1,446,403 | $1,023,999 | $1,180,971 |
| + Debt | $170,568 | $416,990 | $349,799 | $156,450 |
| Enterprise Value | $2,732,611 | $4,113,391 | $5,533,319 | $8,214,698 |
| Revenue | $594,486 | $839,529 | $625,698 | $511,062 |
| % Growth | -29.2% | 34.2% | 22.4% | – |
| Gross Profit | $272,125 | $409,553 | $304,083 | $282,518 |
| % Margin | 45.8% | 48.8% | 48.6% | 55.3% |
| EBITDA | $70,036 | -$248,720 | -$355,079 | -$465,783 |
| % Margin | 11.8% | -29.6% | -56.7% | -91.1% |
| Net Income | $2,961,877 | -$95,477 | -$226,851 | -$358,712 |
| % Margin | 498.2% | -11.4% | -36.3% | -70.2% |
| EPS Diluted | 1.36 | -0.045 | -0.11 | -0.18 |
| % Growth | 3,102.2% | 58.8% | 38.9% | – |
| Operating Cash Flow | $75,647 | -$286,911 | -$120,292 | -$136,790 |
| Capital Expenditures | -$147,920 | -$157,713 | -$203,572 | -$137,397 |
| Free Cash Flow | -$72,273 | -$444,624 | -$323,864 | -$274,187 |